DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia
Reduced expression of the uptake transporter, OCTN1 (SLC22A4), has been reported as a strong predictor of poor event‐free and overall survival in multiple cohorts of patients with acute myeloid leukemia (AML) receiving the cytidine nucleoside analog, cytarabine (Ara‐C). To further understand the mec...
Saved in:
Main Authors: | Daelynn R. Buelow (Author), Jason T. Anderson (Author), Stanley B. Pounds (Author), Lei Shi (Author), Jatinder K. Lamba (Author), Shuiying Hu (Author), Alice A. Gibson (Author), Emily A. Goodwin (Author), Alex Sparreboom (Author), Sharyn D. Baker (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice
by: Jason T. Anderson, et al.
Published: (2019) -
Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia
by: Joana Pereira-Vieira, et al.
Published: (2024) -
Standard dose Cytarabine-Induced Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Report
by: Mehrshad Ebrahimpour, et al.
Published: (2024) -
High-dose cytarabine associated hemorrhagic pericardial effusion in a child with acute myeloid leukemia
by: Swati Kapoor, et al.
Published: (2020) -
Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia
by: Tomislav Smoljo, et al.
Published: (2023)